Home
Scholarly Works
Real-world experience and outcomes of...
Journal article

Real-world experience and outcomes of decitabine/cedazuridine or azacitidine for the treatment of myelodysplastic syndrome/chronic myelomonocytic leukemia

Authors

Salter B; Ge S; Garcia-Horton A; Berg T; Leber B; Walker I; Dalmia S; Radford M; Lepic K; Khalaf D

Journal

Leukemia & Lymphoma, Vol. 67, No. 2, pp. 460–467

Publisher

Taylor & Francis

Publication Date

January 28, 2026

DOI

10.1080/10428194.2025.2577861

ISSN

1042-8194

Contact the Experts team